Both in Pharmaceuticals
ABBVIE vs Vertex Pharmaceuticals
Over the past year ABBV returned +35.2% and VRTX returned +31.3%; their daily moves had a correlation of 0.50.
ABBV +35.2% VRTX +31.3%Growth of $1, one year, split-adjusted
| Metric | ABBV | VRTX |
|---|---|---|
| Price | $294.89 | $558.88 |
| Market cap | $521.11B | $141.65B |
| Today | +1.41% | +3.50% |
| 1 month | +13.4% | +10.3% |
| 6 months | +42.7% | +31.8% |
| Year to date | +29.1% | +23.3% |
| 1 year | +31.0% | +34.0% |
| Revenue growth (YoY) | +10.2% | +12.5% |
| Gross margin | 74.7% | 85.3% |
| Net margin | 21.3% | 33.0% |
| P/E (TTM) | 82.8× | 32.2× |
| Price / sales | 8.1× | 11.3× |
| Net cash | -$64.25B | $7.85B |
| Dividend yield | 2.35% | — |
| Volatility (60d) | 19.6% | 28.7% |
| Short % of float | 0.9% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).